These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates. Nakashima K, Aoshima M, Ohkuni Y, Hoshino E, Hashimoto K, Otsuka Y. J Infect Chemother; 2014 Dec; 20(12):757-61. PubMed ID: 25187511 [Abstract] [Full Text] [Related]
23. Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms. Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE. AIDS; 2013 Mar 27; 27(6):967-972. PubMed ID: 23698062 [Abstract] [Full Text] [Related]
24. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia. Oren I, Hardak E, Finkelstein R, Yigla M, Sprecher H. Am J Med Sci; 2011 Sep 27; 342(3):182-5. PubMed ID: 21642823 [Abstract] [Full Text] [Related]
25. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers. Son HJ, Sung H, Park SY, Kim T, Lee HJ, Kim SM, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. PLoS One; 2017 Sep 27; 12(11):e0188860. PubMed ID: 29190812 [Abstract] [Full Text] [Related]
31. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection. Hardak E, Neuberger A, Yigla M, Berger G, Finkelstein R, Sprecher H, Oren I. Respirology; 2012 May 27; 17(4):681-6. PubMed ID: 22390188 [Abstract] [Full Text] [Related]
32. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients. Grønseth S, Rogne T, Hannula R, Åsvold BO, Afset JE, Damås JK. Microbiol Spectr; 2021 Sep 03; 9(1):e0002621. PubMed ID: 34346746 [Abstract] [Full Text] [Related]
35. Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization. Perret T, Kritikos A, Hauser PM, Guiver M, Coste AT, Jaton K, Lamoth F. J Med Microbiol; 2020 May 03; 69(5):705-711. PubMed ID: 32369002 [Abstract] [Full Text] [Related]
37. Use of β-D-glucan in diagnosis of suspected Pneumocystis jirovecii pneumonia in adults with HIV infection. Juniper T, Eades CP, Gil E, Fodder H, Quinn K, Morris-Jones S, Gorton RL, Wey EQ, Post FA, Miller RF. Int J STD AIDS; 2021 Oct 03; 32(11):1074-1077. PubMed ID: 34106017 [Abstract] [Full Text] [Related]
39. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR. Szvalb AD, Malek AE, Jiang Y, Bhatti MM, Wurster S, Kontoyiannis DP. J Infect; 2020 Sep 03; 81(3):443-451. PubMed ID: 32650108 [Abstract] [Full Text] [Related]
40. Evaluation of the PneumoGenius® PCR assay for the diagnosis of Pneumocystis pneumonia and the detection of Pneumocystis dihydropteroate synthase mutations in respiratory samples. Guegan H, Roojee M, Le Gal S, Artus M, Nevez G, Gangneux JP, Robert-Gangneux F. Med Mycol; 2023 Apr 03; 61(4):. PubMed ID: 37028929 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]